Cargando…

Use of antibiotics and colorectal cancer risk: a primary care nested case–control study in Belgium

OBJECTIVES: To examine the association between the use of oral antibiotics and subsequent colorectal cancer risk. DESIGN: Matched case–control study. SETTING: General practice centres participating in the Integrated Computerised Network database in Flanders, Belgium. PARTICIPANTS: In total, 1705 cas...

Descripción completa

Detalles Bibliográficos
Autores principales: Van der Meer, Johannes, Mamouris, Pavlos, Nassiri, Vahid, Vaes, Bert, van den Akker, Marjan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666897/
https://www.ncbi.nlm.nih.gov/pubmed/34893485
http://dx.doi.org/10.1136/bmjopen-2021-053511
_version_ 1784614291270270976
author Van der Meer, Johannes
Mamouris, Pavlos
Nassiri, Vahid
Vaes, Bert
van den Akker, Marjan
author_facet Van der Meer, Johannes
Mamouris, Pavlos
Nassiri, Vahid
Vaes, Bert
van den Akker, Marjan
author_sort Van der Meer, Johannes
collection PubMed
description OBJECTIVES: To examine the association between the use of oral antibiotics and subsequent colorectal cancer risk. DESIGN: Matched case–control study. SETTING: General practice centres participating in the Integrated Computerised Network database in Flanders, Belgium. PARTICIPANTS: In total, 1705 cases of colorectal cancer diagnosed between 01 January 2010 and 31 December 2015 were matched to 6749 controls by age, sex, comorbidity and general practice centre. PRIMARY OUTCOME MEASURE: The association between the number of prescriptions for oral antibiotics and the incidence of colorectal cancer over a period of 1–10 years, estimated by a conditional logistic regression model. RESULTS: A significantly increased risk of colorectal cancer (OR 1.25, 95% CI 1.10 to 1.44) was found in subjects with one or more prescriptions compared with those with none after correction for diabetes mellitus. No dose-response relationship was found. CONCLUSIONS: This study resulted in a modestly higher risk of having colorectal cancer diagnosed after antibiotic exposure. The main limitation was missing data on known risk factors, in particular smoking behaviour. This study did not allow us to examine the causality of the relationship, indicating the need of further investigation.
format Online
Article
Text
id pubmed-8666897
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-86668972021-12-28 Use of antibiotics and colorectal cancer risk: a primary care nested case–control study in Belgium Van der Meer, Johannes Mamouris, Pavlos Nassiri, Vahid Vaes, Bert van den Akker, Marjan BMJ Open Epidemiology OBJECTIVES: To examine the association between the use of oral antibiotics and subsequent colorectal cancer risk. DESIGN: Matched case–control study. SETTING: General practice centres participating in the Integrated Computerised Network database in Flanders, Belgium. PARTICIPANTS: In total, 1705 cases of colorectal cancer diagnosed between 01 January 2010 and 31 December 2015 were matched to 6749 controls by age, sex, comorbidity and general practice centre. PRIMARY OUTCOME MEASURE: The association between the number of prescriptions for oral antibiotics and the incidence of colorectal cancer over a period of 1–10 years, estimated by a conditional logistic regression model. RESULTS: A significantly increased risk of colorectal cancer (OR 1.25, 95% CI 1.10 to 1.44) was found in subjects with one or more prescriptions compared with those with none after correction for diabetes mellitus. No dose-response relationship was found. CONCLUSIONS: This study resulted in a modestly higher risk of having colorectal cancer diagnosed after antibiotic exposure. The main limitation was missing data on known risk factors, in particular smoking behaviour. This study did not allow us to examine the causality of the relationship, indicating the need of further investigation. BMJ Publishing Group 2021-12-10 /pmc/articles/PMC8666897/ /pubmed/34893485 http://dx.doi.org/10.1136/bmjopen-2021-053511 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Epidemiology
Van der Meer, Johannes
Mamouris, Pavlos
Nassiri, Vahid
Vaes, Bert
van den Akker, Marjan
Use of antibiotics and colorectal cancer risk: a primary care nested case–control study in Belgium
title Use of antibiotics and colorectal cancer risk: a primary care nested case–control study in Belgium
title_full Use of antibiotics and colorectal cancer risk: a primary care nested case–control study in Belgium
title_fullStr Use of antibiotics and colorectal cancer risk: a primary care nested case–control study in Belgium
title_full_unstemmed Use of antibiotics and colorectal cancer risk: a primary care nested case–control study in Belgium
title_short Use of antibiotics and colorectal cancer risk: a primary care nested case–control study in Belgium
title_sort use of antibiotics and colorectal cancer risk: a primary care nested case–control study in belgium
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666897/
https://www.ncbi.nlm.nih.gov/pubmed/34893485
http://dx.doi.org/10.1136/bmjopen-2021-053511
work_keys_str_mv AT vandermeerjohannes useofantibioticsandcolorectalcancerriskaprimarycarenestedcasecontrolstudyinbelgium
AT mamourispavlos useofantibioticsandcolorectalcancerriskaprimarycarenestedcasecontrolstudyinbelgium
AT nassirivahid useofantibioticsandcolorectalcancerriskaprimarycarenestedcasecontrolstudyinbelgium
AT vaesbert useofantibioticsandcolorectalcancerriskaprimarycarenestedcasecontrolstudyinbelgium
AT vandenakkermarjan useofantibioticsandcolorectalcancerriskaprimarycarenestedcasecontrolstudyinbelgium